Senseera specializes in developing liquid biopsy blood tests for the early detection and monitoring of human diseases.
Senseera Health has raised $7.1M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
Senseera Health's investors include Lightspeed Venture Partners, I-Next Ventures.
Senseera Health is headquartered in Jerusalem, Israel.
Senseera specializes in developing liquid biopsy blood tests for the early detection and monitoring of human diseases.
Senseera Health is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Senseera Health — Funding & Investors." VCBacked, January 7, 2025, https://www.vcbacked.co/company/senseera-health. Accessed October 18, 2026.
VCBacked. (2025). Senseera Health — Funding & Investors. Retrieved October 18, 2026, from https://www.vcbacked.co/company/senseera-health
{{cite web |title=Senseera Health — Funding & Investors |url=https://www.vcbacked.co/company/senseera-health |website=VCBacked |access-date=October 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated